Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates

Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates

17 Pág.

Saved in:
Bibliographic Details
Main Authors: Pérez Ramírez, Patricia, Albericio, Guillermo, Astorgano, David, Flores, Sara, Sánchez-Corzo, Cristina, Sánchez-Cordón, P. J., Luczkowiak, Joanna, Delgado, Rafael, Casasnovas, José María, Esteban, Mariano, García-Arriaza, Juan
Other Authors: Ministerio de Sanidad (España)
Format: artículo biblioteca
Language:English
Published: Frontiers Media 2023-12-12
Subjects:COVID-19, MVA-based vaccine, S protein, SARS-CoV-2, Efficacy, Immunogenicity, Mice, Variants of concern,
Online Access:http://hdl.handle.net/10261/349371
http://dx.doi.org/10.13039/501100003339
http://dx.doi.org/10.13039/501100004837
http://dx.doi.org/10.13039/501100004587
http://dx.doi.org/10.13039/501100000780
http://dx.doi.org/10.13039/501100011033
https://api.elsevier.com/content/abstract/scopus_id/85180695762
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:17 Pág.

Similar Items